Patent · US Active

Materials and methods for gene mediated therapy of psychiatric disorders

US8642341B2 · kind B2 · utility

0Cited by

4References

13Claims

0Family size

Assignee

Cornell University · IT

Inventors

Michael Kaplitt · New York, US
Brian Alexander · Melbourne, AU

Key dates

Filing date	Oct 31, 2008
Grant date	Feb 4, 2014
Priority date	—
Expiry date	Feb 17, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K14/4702
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides materials and methods for p11-mediated therapy of psychiatric disorders. The invention provides vectors for increasing p11 expression and methods of treating a mammal with one or more symptoms of a psychiatric disorder. The invention also provides methods for improving a mammal's responsiveness to treatment for a psychiatric disorder. The invention further provides model animals for depression and depression therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.